基石药业（苏州）有限公司 CSTONE PHARMACEUTICALS
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CStone files CS1003, an anti-PD-1 antibody, for clinical trial approval in Australia 2017-12-28 10:45
CStone files MEK inhibitor CS3006 for clinical trial approval in Australia 2017-12-27 15:41
Opening Ceremony of CStone Pharmaceuticals' Suzhou Translational Medicine Research Center and an associated Immuno-Oncology Forum was Successfully Held in Suzhou 2017-11-03 14:16
CStone Pharmaceuticals Announces Dosing the First Patient of CS1001: China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody 2017-10-20 20:50
China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration 2017-07-17 20:50
1 4 5 6 7 8